-
Sector Analysis
NewAirport Retailing Market Size, Trends and Analysis by Regional and Category Performance, Brands and Forecast to 2028
Airport Retailing Market Report Overview The airport retailing market size was valued at $35.2 billion in 2023. The airport retailing market benefited from an increase in air traffic and airport retailers capitalized on this by expanding their presence across different markets. Furthermore, airport retailers adopting innovative omnichannel initiatives will support the market growth recording a CAGR of more than 9% during 2023-2028. Airport Retailing Market Outlook, 2023-2028 ($ Billion) Buy the Full Report for More Insights into the Airport Retailing Market...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Crenigacestat in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Crenigacestat in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Crenigacestat in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Crenigacestat (LY-3039478)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UCLM-802 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - UCLM-802 in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. UCLM-802 in Endometrial Cancer Drug Details: UCLM-802 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tafoxiparin Sodium in Pre-Eclampsia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tafoxiparin Sodium in Pre-Eclampsia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tafoxiparin Sodium in Pre-Eclampsia Drug Details: DF-01 (tafoxiparin) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LT-1001 in Acute Respiratory Distress Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LT-1001 in Acute Respiratory Distress Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LT-1001 in Acute Respiratory Distress Syndrome Drug Details: LT-1001 (PC-SOD,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DF-1001 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DF-1001 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DF-1001 in Colorectal Cancer Drug Details: DF-1001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elenagen in Uterine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elenagen in Uterine Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elenagen in Uterine Cancer Drug Details: Elenagen is under development for the...